Skip to content

Clinical trials

Breast Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Country / region: Japan Clear all

247 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20032
20042
20058
20068
20077
20089
20099
20109
20118
20128
20135
201413
201510
20162
201714
201812
201910
202012
202121
202212
202313
202414
202521
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed123
Active, not recruiting57
Recruiting41
Terminated20
Not yet recruiting2
Enrolling by invitation2
Approved for marketing1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca34
Novartis Pharmaceuticals24
Pfizer24
Eli Lilly and Company20
Hoffmann-La Roche16
GlaxoSmithKline7
Daiichi Sankyo6
Eisai Co., Ltd.6
Merck Sharp & Dohme LLC6
Bayer4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms247
Neoplasm Metastasis29
Neoplasms27
Carcinoma, Non-Small-Cell Lung18
Ovarian Neoplasms18
Endometrial Neoplasms15
Triple Negative Breast Neoplasms15
Colorectal Neoplasms13
Stomach Neoplasms13
Uterine Cervical Neoplasms10

Trials

Showing 51 to 75 of 247. Each trial links to its page on Pharma Observatory.

147 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.